Regeneron wins ultra-rare disease drug approval, a validating win for mRNA research, and more biotech news from The Readout ...
The Trump administration wanted acting FDA Commissioner Kyle Diamantas to accept the job permanently. He declined, so they ...
A Regeneron drug for an ultra-rare disease that causes bone to grow where it shouldn't won U.S. regulatory approval, capping ...
Heidi Overton's rise under Trump, inside a 5-year-old brain organoid, and other health news from Morning Rounds ...
Regulatory flexibility can be exercised in rare disease without sacrificing rigor,” writes Mindy Leffler, whose son has ...
Between success with a pancreatic cancer drug and now success with an mRNA neoantigen vaccine, it has been a banner year for ...
Washington has rediscovered faith as a delivery mechanism. The bigger opportunity is faith as a source of capital,” writes Dr ...
Males make up about a third of the population struggling with eating disorders in the United States. While these conditions ...
Capricor Therapeutics is trying to stave off FDA rejection of its cell therapy for Duchenne muscular dystrophy.
Reducing protein intake could increase human longevity, researchers recently suggested. That's a bad idea, for several ...
Dear Readers, When we launched STAT more than a decade ago, our mission statement promised that we would deliver "trusted, ...
A personalized mRNA cancer vaccine succeeded in a late-stage melanoma study, results that could herald a new, powerful ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results